Skip Navigation Links

Request For Applications (RFAs)

The NINR invites grant proposals in the following defined areas of research. RFAs are one-time opportunities with one submission date. The RFA is closed after its expiration date. All RFAs, active or inactive may be viewed in current or previous issues of the NIH Guide for Grants and Contracts
Displaying 1 - 16 of 16
Title: HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)
Announcement Number: RFA-AT-20-004
Release Date: Thursday, January 23, 2020
Expiration Date: Tuesday, March 31, 2020
Activity Code: UG3/UH3
Title: HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Announcement Number: RFA-NS-20-028
Release Date: Tuesday, January 21, 2020
Expiration Date: Wednesday, March 25, 2020
Activity Code: UG3/UH3
Title: HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Announcement Number: RFA-NS-20-028
Release Date: Tuesday, January 21, 2020
Expiration Date: Wednesday, March 25, 2020
Activity Code: UG3/UH3
Title: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
Announcement Number: RFA-OD-20-003
Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R61/R33
Title: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
Announcement Number: RFA-OD-20-004
Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R21
Title: NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP-ENDURE) (R25 Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-015
Release Date: Tuesday, November 19, 2019
Expiration Date: Thursday, February 20, 2020
Activity Code: R25
Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
Announcement Number: RFA-NS-20-008
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R41/R42
Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-009
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R41/R42
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
Announcement Number: RFA-NS-20-010
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-011
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
Announcement Number: RFA-OD-19-029
Release Date: Friday, September 27, 2019
Expiration Date: Saturday, November 27, 2021
Activity Code: R01
Title: HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
Announcement Number: RFA-NS-19-016
Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: UG3/UH3
Title: HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
Announcement Number: RFA-NS-19-017
Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: U44
Title: HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
Announcement Number: RFA-NS-19-018
Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: UH3
Title: Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
Announcement Number: RFA-NS-18-046
Release Date: Wednesday, September 19, 2018
Expiration Date: Friday, March 13, 2020
Activity Code: R61/R33
Title: Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
Announcement Number: RFA-NS-18-041
Release Date: Thursday, August 2, 2018
Expiration Date: Friday, March 13, 2020
Activity Code: R61/R33
Arrow Up Back to Top